Semler Scientific 將比特幣持有量增加至 2,321 BTC，報告 BTC 收益率為 72.6%

加州聖克拉拉 - Semler Scientific, Inc.（納斯達克股票代碼：SMLR）是一家專門從事醫療保健技術產品的公司，毛利率高達 88%，令人印象深刻

Semler Scientific, Inc. (NASDAQ:SMLR) has disclosed recent activities surrounding its bitcoin (CRYPTO: BTCUSD) investments and capital market strategies, including its at-the-market (ATM) equity offering program.

Semler Scientific, Inc.（納斯達克股票代碼：SMLR）揭露了近期圍繞其比特幣（加密貨幣：BTCUSD）投資和資本市場策略的活動，包括其市場（ATM）股票發行計劃。

According to InvestingPro analysis, the company maintains excellent financial health with strong profitability metrics and operates with minimal debt.

根據 InvestingPro 的分析，該公司保持著良好的財務健康狀況和強勁的獲利指標，並以最低的債務運作。

The company's latest bitcoin purchases were made between December 16, 2024, and January 10, 2025,Spesifikasi Lengkap - Gempa Turki Hari Ini: Korban Tewas Capai 2.316 Jiwa, Ribuan Bangunan Runtuh with an average price of $98,267 per coin, totaling $23.3 million. These purchases were funded through the company's ATM offering and operating cash flow.

該公司最新的比特幣購買時間為2024年12月16日至2025年1月10日，完整規格－今日土耳其地震：死亡人數達2,316人，數千棟建築物倒塌，平均每枚比特幣價格為98,267美元，總計2,330萬美元。這些購買的資金來自該公司的 ATM 發行和營運現金流。

As a result, Semler Scientific's total bitcoin holdings reached 2,321 bitcoins with an aggregate investment of $191.9 million, averaging $82,687 per bitcoin, inclusive of fees and expenses.

結果，Semler Scientific 的比特幣總持有量達到 2,321 個比特幣，總投資額為 1.919 億美元，平均每比特幣價值 82,687 美元，包括費用和支出。

The company's strong liquidity position, with a current ratio of 3.14, supports these strategic investments while maintaining operational flexibility.

該公司強大的流動性狀況（流動比率為3.14）支持這些策略投資，同時保持營運靈活性。

In terms of capital market activities, Semler Scientific, under a Sales Agreement with Cantor Fitzgerald & Co., may periodically sell its common stock through an ATM offering.

在資本市場活動方面，Semler Scientific 根據與 Cantor Fitzgerald & Co. 的銷售協議，可以定期透過 ATM 發行出售其普通股。

On December 16, 2024, the company filed a prospectus supplement to increase the total amount offered under the ATM to $150.0 million. As of January 10, 2025, approximately $121.8 million in gross proceeds had been generated from these sales.

2024 年 12 月 16 日，該公司提交了招股說明書補充文件，將 ATM 下的發行總額增加至 1.5 億美元。截至 2025 年 1 月 10 日，這些銷售已產生約 1.218 億美元的總收益。

Semler Scientific also reported a BTC Yield of 72.6% from October 1, 2024, to January 10, 2025, and a yield of 99.3% from July 1, 2024, to January 10, 2025.

Semler Scientific也報告稱，從2024年10月1日到2025年1月10日，比特幣收益率為72.6%，從2024年7月1日到2025年1月10日，比特幣收益率為99.3 %。

BTC Yield, a key performance indicator (KPI), is used by the company to assess the performance of its bitcoin acquisition strategy, which it believes is accretive to stockholders.

BTC 收益率是一項關鍵績效指標 (KPI)，該公司使用它來評估其比特幣收購策略的績效，該公司認為該策略對股東有利。

However, it is important to note that BTC Yield is not a traditional financial measure and does not equate to a return on investment or income generated by the company's operations or bitcoin holdings.

然而，值得注意的是，比特幣收益率並不是傳統的金融衡量標準，並不等於公司營運或持有比特幣所產生的投資報酬或收入。

The trading price of Semler Scientific's common stock, currently at $51.36 with a market capitalization of $476 million, may be influenced by factors beyond the company's bitcoin holdings and share count.

Semler Scientific 普通股的交易價格目前為 51.36 美元，市值為 4.76 億美元，可能會受到公司比特幣持有量和股票數量以外的因素的影響。

InvestingPro analysis indicates the stock is trading above its Fair Value, with an EV/EBITDA multiple of 22.8x.

InvestingPro 分析表明，該股的交易價格高於其公允價值，EV/EBITDA 倍數為 22.8 倍。

Moreover, the company has not historically paid dividends on its common stock, and the BTC Yield KPI does not imply any future intention to do so.

此外，該公司歷史上從未支付過普通股股息，而比特幣收益率 KPI 並不意味著未來有任何這樣做的打算。

Investors seeking deeper insights can access comprehensive valuation metrics and 14 additional ProTips through InvestingPro's detailed research reports, available for over 1,400 US stocks.

尋求更深入見解的投資者可以透過 InvestingPro 的詳細研究報告獲取全面的估值指標和 14 個額外的專業提示，這些報告涵蓋 1,400 多隻美國股票。

This information is based on a press release statement from Semler Scientific, Inc. Investors are advised to consult financial statements and other disclosures in the company's SEC filings for a comprehensive understanding of the company's activities and financial health.

此資訊是根據 Semler Scientific, Inc. 的新聞稿。

In other recent news, Semler Scientific has made notable strides in expanding its Bitcoin holdings and capital market activities.

在最近的其他新聞中，塞姆勒科學公司在擴大其比特幣持有量和資本市場活動方面取得了顯著進展。

The company recently acquired an additional 211 bitcoins, bringing its total investment to 2,084 bitcoins, purchased with an aggregate of $168.6 million.

該公司最近又購買了 211 個比特幣，使其總投資達到 2,084 個比特幣，購買總額為 1.686 億美元。

This acquisition was funded through its at-the-market (ATM) offering and operating cash flow.

此次收購的資金來自其市場（ATM）發行和營運現金流。

In addition, Semler Scientific has filed a second prospectus supplement to raise an additional $50 million through its ATM offering, in partnership with Cantor Fitzgerald & Co, increasing the total amount offered to $150 million.

此外，Semler Scientific 也提交了第二份招股說明書補充文件，與 Cantor Fitzgerald & Co 合作，透過 ATM 發行額外籌集 5,000 萬美元，使發行總額增加至 1.5 億美元。

Semler Scientific reported a BTC Yield of 67.0% from October 1 to December 15, indicating the performance of its Bitcoin acquisition strategy. However, the company acknowledges that this KPI is not a measure of operational performance or liquidity.

Semler Scientific 報告稱，從 10 月 1 日到 12 月 15 日，比特幣收益率為 67.0%，顯示其比特幣收購策略的表現。然而，該公司承認該關鍵績效指標並不是衡量營運績效或流動性的指標。

Turning to earnings, Semler Scientific reported a decrease in revenues by 17% year-over-year to $13.5 million in the third quarter of 2024, while its income from operations remained robust at $5.1 million. Despite the decline in revenues, the company saw a gain from the change in fair value of its Bitcoin holdings.

談到收益，Semler Scientific 報告稱，2024 年第三季營收年減 17%，至 1,350 萬美元，但營運收入仍保持強勁，達到 510 萬美元。儘管收入下降，但該公司從其持有的比特幣公允價值變化中獲得了收益。

These recent developments underscore Semler Scientific's dual focus on its core medical technology business and its assertive Bitcoin investment strategy. As the company navigates this balance, stakeholders will observe how these dual priorities progress in the upcoming quarters.

這些最新進展凸顯了 Semler Scientific 對其核心醫療技術業務和堅定的比特幣投資策略的雙重關注。當公司尋求這種平衡時，利害關係人將觀察這些雙重優先事項在未來幾季的進展。

This article was generated with the support of AI and reviewed by an editor. For more information see our T

本文是在人工智慧的支援下產生的，並經過編輯審查。欲了解更多信息，請參閱我們的 T